Brellium Secures $13.7 Million in Series A Funding for AI-Powered Clinical Compliance Platform
Brellium has successfully raised $13.7 million in Series A funding for its advanced AI-Powered clinical compliance platform. The funding round was co-led by First Round Capital and Left Lane Capital, with additional support from Menlo Ventures, Digital Health Venture Partners, and Necessary Ventures, as well as several angel investors such as Andrew Adams, Steve Gutentag, Demitri Karagas, Cory Levy, and Fiat Ventures.
This investment will be utilized by Brellium to expand its team and accelerate its product roadmap, enhancing its offerings in the healthcare compliance sector.
Under the leadership of CEO Zach Rosen, Brellium offers a cutting-edge AI platform designed to assist healthcare providers in streamlining compliance processes for millions of patient visits. By utilizing this platform, clinical teams can ensure that each patient visit meets the required payor and clinical quality standards, all while reducing manual workload. Brellium conducts proactive audits of every patient visit, identifying compliance risks before they escalate. Providers are promptly notified of any necessary corrections in patient charts, along with clear instructions on how to resolve them.
The company’s clientele includes esteemed healthcare organizations such as Grow Therapy, Rula, Headspace, Hopebridge, Lightfully Behavioral Health, Talkiatry, among others.
FinSMEs
21/04/2025
